beta
AGLE
Aeglea BioTherapeutics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.
Market Cap: 111 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.aegleabio.com
Shares Outstanding: 16.6 Million
Float: 16.2 Million
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector: Healthcare
Industry: Biotechnology
Short Interest (Jan 12, 2018): 38.4 Thousand
Ethical Flags
Longest drawdown: 1403 trading days
From: 2016-04-08 To: 2019-10-18
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|